Article Information
History
- December 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sara Al Rawi1,*,
- Lorna Simpson1,*,
- Neil Q. McDonald2,
- Veronika Chernuha3,
- Orly Elpeleg4,
- Massimo Zeviani5,
- Roger A. Barker6,
- Ronen Spiegel7,^ and
- Heike Laman1,8,^
- 1University of Cambridge, Department of Pathology, Tennis Court Road, CB2 1QP
- 2Signalling and Structural Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT and also Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, London, WC1E 7HX, UK
- 3Pediatric Neurology Institute, Dana-Dwek Children’s Hospital, Tel Aviv Medical Centre and Sackler Faculty of Medicine, Tel Aviv, Israel
- 4Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
- 5Mitochondrial Biology Unit, The MRC and University of Cambridge, Cambridge CB2 0XY, UK. Department of Neurosciences, University of Padova, 35128 Padova, Italy
- 6John van Geest Centre for Brain Repair, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY 0PY and Wellcome-MRC Cambridge Stem Cell Institute
- 7Pediatric Department, Emek Medical Center, Afula 18101, Israel
- ↵8Corresponding author: hl316{at}cam.ac.uk; +44(0)1223 333722
↵* Equal contribution
Posted December 23, 2021.
Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria
